Quantcast
Last updated on April 20, 2014 at 1:20 EDT

Latest Protein Sciences Stories

2013-02-20 16:25:28

MERIDEN, Conn., Feb. 20, 2013 /PRNewswire/ -- The Meriden Department of Health and Human Services will host a free walk-in Flublok influenza vaccine clinic on Thursday, February 21, from 9:00am to 5:00pm at 165 Miller Street in Meriden. Those between the ages of 18 to 49 are able to receive the vaccine. No appointments are necessary and you do not have to live in Meriden. "The timing of this is great as we are still urging people to get vaccinated against the flu. Flu activity will likely...

2013-02-20 12:26:26

MERIDEN, Conn., Feb. 20, 2013 /PRNewswire/ -- Protein Sciences Corporation announced today that Wayne Hachey, DO (Colonel, U.S. Army, ret.) has joined the Company's management as Head, Government and Clinical Affairs. Dr. Hachey is a physician who has dedicated 28 years of service to the military healthcare system, including six years as a subject matter expert advising senior Department of Defense (DoD) leadership regarding the DoD's vaccine policy. He was also responsible for developing...

2013-02-15 16:23:21

PEARL RIVER, N.Y., Feb. 15, 2013 /PRNewswire/ -- At a press conference today showcasing Protein Sciences' newly leased manufacturing facility for Flublok, the Company announced that the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services, will continue to support the Company's influenza vaccines program. BARDA held an internal review of the Protein Sciences program and made a decision to modify its contract with the...

FDA Approves Flublok Flu Vaccine
2013-01-17 19:32:51

Lee Rannals for redOrbit.com — Your Universe Online A new flu vaccine won regulatory approval on Wednesday and its limited supplies are expected to be available this winter. Protein Sciences won the approval for Flublok, which is made with a process that does not require the virus to be grown in chicken eggs. “This approval represents a technological advance in the manufacturing of an influenza vaccine,” Dr. Karen Midthun, a senior official at the U.S. Food and...

2013-01-16 20:21:40

MERIDEN, Conn., Jan. 16, 2013 /PRNewswire/ -- The U.S. FDA approved Flublok for people 18-49 years old - making it the first recombinant vaccine for influenza available on the market. Approval for all people 18 years and above is expected later in 2013. Flublok features: First influenza vaccine made without the use of live influenza virus First egg-free influenza vaccine Highly purified without preservatives (thimerosal), antibiotics or adjuvants Three times the active ingredient...

2012-10-24 07:32:12

MERIDEN, Conn., Oct. 24, 2012 /PRNewswire/ -- Protein Sciences announced that Tim Fields, Vice President of Quality, was named recipient of the Ken Chapman Industry Recognition Award during the International Validation Week Conference presented by the Institute of Validation Technology (IVT) on Oct. 23, 2012. Ken Chapman who died of pancreatic cancer in 2006 was renowned for his forward-thinking approach to regulatory issues and best practices. Many of his ideas have become standard in...

2012-09-10 06:29:58

MERIDEN, Conn., Sept. 10, 2012 /PRNewswire/ -- Protein Sciences Corporation announced that this afternoon there will be a presentation of clinical data for the pandemic (monovalent) formulation of Protein Sciences innovative solution for protection from influenza, FluBlok, by John Treanor, MD, Chief of the Infectious Diseases Division of the Department of Medicine at the University of Rochester Medical Center. The presentation will occur at the Interscience Conference on Antimicrobial Agents...

2012-04-30 02:26:20

MERIDEN, Conn., April 30, 2012 /PRNewswire/ -- Protein Sciences Corporation has expanded its senior management team by adding leaders in the areas of manufacturing and finance. The additions come at a time of great anticipation as the Company prepares for the launch of its first product, FluBlok®, a first-in-class recombinant vaccine for seasonal influenza. Mireli Fino joins us as VP, Manufacturing Operations. She comes from Wyeth (now Pfizer) where she spent the past 20 years in...

2012-02-22 08:00:00

MERIDEN, Conn., Feb. 22, 2012 /PRNewswire/ -- Protein Sciences Corporation ("Protein Sciences") announced today that it has granted Merck, through a subsidiary, a non-exclusive license to Protein Sciences' proprietary expresSF+® serum-free insect cell line (SF+) and related technology (collectively, PS Technology) to conduct vaccine research. In addition, Protein Sciences has granted Merck an exclusive license to use PS Technology for commercial production of an undisclosed vaccine...

2010-11-03 08:00:00

MERIDEN, Conn., Nov. 3, 2010./PRNewswire/ -- Protein Sciences Corporation (PSC) announced today that the Company and its management have reached an agreement with Emergent BioSolutions, Inc (Emergent) resolving all remaining issues from the failed attempt by Emergent to purchase PSC's assets in June 2008. As a result, all litigation will be dismissed with prejudice and all other entanglements between the two companies will be ended. Daniel Adams, Executive Chairman, said, "With this deal...